4.3 Article

In multiple sclerosis anxiety, not depression, is related to gender

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 22, 期 2, 页码 239-244

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458515588582

关键词

Multiple sclerosis; depression; anxiety; gender

资金

  1. BiogenIdec
  2. Pfizer
  3. Merck Serono
  4. Novartis
  5. Biogen
  6. MS Society of Canada

向作者/读者索取更多资源

Background: There is a high prevalence of depressive and anxiety disorders in multiple sclerosis (MS), a disease 2.5 times more frequent in females. Contrary to the general population, in whom studies have demonstrated higher rates of depression and anxiety in females, little is known about the impact of gender on psychiatric sequelae in MS patients. Objectives: We conducted a retrospective study to try to clarify this uncertainty. Methods: Demographic, illness-related and behavioral variables were obtained from a neuropsychiatric database of 896 patients with a confirmed diagnosis of MS. Symptoms of depression and anxiety were obtained with the Hospital Anxiety and Depression Scale (HADS). Gender comparisons were undertaken and predictors of depression and anxiety sought with a linear regression analysis. Results: HADS data were available for 711 of 896 (79.35%) patients. Notable gender differences included a higher frequency of primary progressive MS in males (p = 0.002), higher HADS anxiety scores in females (p < 0.001), but no differences in HADS depression scores. Conclusion: In MS, gender influences the frequency of anxiety only. This suggests that the etiological factors underpinning anxiety and depression in MS are not only different from one another, but also in the case of depression, different from those observed in general population samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据